Keywords
Bacteremia
Intensive Care Units
Anti-bacterial Agents
Drug Resistance
Microbial
Infection Control
How to Cite
Abstract
Introduction: antibiotic therapy is an effective treatment for many types of infections, but their overuse promotes the spread of resistant microorganisms, which is associated with increases in morbidity, mortality, length of stay, and hospital expenditures; a frequent difficulty in the intensive care unit. Objective: to evaluate the prevalence of microorganisms and describe the profiles of bacterial resistance in isolated foci of patients in one intensive care unit in Pereira. Materials and method: a retrospective study was performed. Sensitivity and resistance profiles of hospitalized patients during the first half of 2015 were analyzed. The information was extracted from clinical histories and laboratory reports. Antimicrobial susceptibility testing was performed with WHONET. Trend analyzes were done with STATA. Results: 62 patients were included with a mean age of 57.9 years, 32 were female. The highest positivity was for blood cultures and urine cultures. The most frequently isolated microorganisms were: E. coli (resistance of 95%, 75% and 70% for ampicillin, cefazoline and piperaziline/ tazobactam respectively), K. pneumonia (resistance of 46% to ampicillin/sulbactam, piperaziline/tazobactam and cefazolina), S. aureus and P. aeruginosa. Conclusion: Resistance profile found is alarming, associated with a high prevalence of Ampc-type β-lactamases (n=16)
and extended-spectrum β-lactamases (n=8). E. coli, K. pneumoniae and P. aeruginosa exhibit important resistance values for antibiotics commonly used in UCI as broad-spectrum penicillins and cephalosporins. MÉD.UIS. 2018;31(2):9-15.
References
2. Streit JM, Jones RN, Sader HS, Fritsche TR. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents. 2004 Aug;24(2):111-8.
3. Yildirim S, Nursal TZ, Tarim A, Torer N, Noyan T, Demiroglu YZ, et al. Bacteriological profile and antibiotic resistance: comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center. J Burn Care Res. 2005;26(6):488-92.
4. Rhomberg PR, Fritsche TR, Sader HS, Jones RN. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Diagn Microbiol Infect Dis. 2006 Sep;56(1):57-62.
5. Strich JR, Palmore TN. Preventing Transmission of MultidrugResistant Pathogens in the Intensive Care Unit. Infect Dis Clin North Am. 2017 Sep;31(3):535-50.
6. Katsios CM, Burry L, Nelson S, Jivraj T, Lapinsky SE, Wax RS, et al. An antimicrobial stewardship program improves
antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care. 2012
Nov 5;16(6):R216.
7. Meric M, Willke A, Caglayan C, Toker K. Intensive care unitacquired infections: incidence, risk factors and associated
mortality in a Turkish university hospital. Jpn J Infect Dis. 2005 Oct;58(5):297-302.
8. Chelazzi C, Pettini E, Villa G, De Gaudio AR. Epidemiology, associated factors and outcomes of ICU-acquired infections caused by Gram-negative bacteria in critically ill patients: an observational, retrospective study. BMC anesthesiol. 2015;15(1):125-32.
9. Fihman V, Messika J, Hajage D, Tournier V, Gaudry S, Magdoud F, et al. Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption. Int J Antimicrob Agents. 2015;46(5):18-25.
10. Pulcini C, Dellamonica J, Bernardin G, Molinari N, Sotto A. Impact of an intervention designed to improve the documentation of the reassessment of antibiotic therapies in an intensive care unit. Med Mal Infect. 2011;41(10):546-52.
11. Amer MR, Akhras NS, Mahmood WA, Al-Jazairia AS.